Acyclovir Dosage for Obese Patients

We are exploring how to personalize acyclovir dosages for individuals with obesity. This study aims to improve treatment effectiveness and safety for this patient group.

Safety phase (I)Infectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Toulouse
SMIT
Toulouse, France
Sponsor: Centre Hospitalier Universitaire De Toulouse
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.